Bracco at ECR 2025: Innovations in Contrast Media and Sustainability
Bracco brings actionable solutions for ‘Planet Radiology’ to ECR2025
Bayer at ECR 2025: Shaping Radiology with Contrast & AI
ECR 2025 Shines a Spotlight on Next-Generation Imaging Innovations
Positive results from Phase III study for Bayer’s investigational contrast agent gadoquatrane
SIRM2024: Giovagnoni on Oncology and the Olympics
SIRM2024: Bracco on New Contrast & Trends in EMEA
More articles
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.
